Literature DB >> 17003447

Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.

Narayan P S Cheruvu1, Uday B Kompella.   

Abstract

PURPOSE: To determine the influence of the choroid-Bruch's layer and solute lipophilicity on in vitro transscleral drug permeability in bovine and porcine eyes.
METHODS: The in vitro permeability of two VEGF inhibitory drugs, budesonide and celecoxib, which are lipophilic and neutral at physiologic pH, and of three marker solutes, 3H-mannitol (hydrophilic, neutral), sodium fluorescein (hydrophilic, anionic), and rhodamine 6G (lipophilic, cationic), were determined across freshly excised scleras, with or without the underlying choroid-Bruch's layer. Select studies were performed using porcine sclera with and without choroid-Bruch's layer. Neural retina was removed by exposure of the eyecup to isotonic buffer and wherever required, the retinal pigment epithelial (RPE) layer of the preparation was disrupted and removed by exposure to hypertonic buffer. Because of the poor solubility of celecoxib and budesonide, permeability studies were conducted with 5% wt/vol of hydroxypropyl-beta-cyclodextrin (HPbetaCD). For other solutes, permeability studies were conducted, with and without HPbetaCD. Partitioning of the solutes into bovine sclera and choroid-Bruch's layer was also determined.
RESULTS: The calculated log (distribution coefficient) values were -2.89, -0.68, 2.18, 3.12, and 4.02 for mannitol, sodium fluorescein, budesonide, celecoxib, and rhodamine 6G, respectively. Removal of RPE was confirmed by transmission electron microscopy and differences in the transport of mannitol. The order of the permeability coefficients (Papp) across sclera and sclera-choroid-Bruch's layers in bovine and porcine models was 3H-mannitol > fluorescein > budesonide > celecoxib > rhodamine 6G, with HPbetaCD, and 3H-mannitol > fluorescein > rhodamine 6G, without HPbetaCD. The presence of choroid-Bruch's layer reduced the bovine scleral permeability by 2-, 8-, 16-, 36-, and 50-fold and porcine tissue permeability by 2-, 7-, 15-, 33-, and 40-fold, respectively, for mannitol, sodium fluorescein, budesonide, celecoxib, and rhodamine 6G. The partition coefficients measured in bovine tissues correlated positively with the log (distribution coefficient) and exhibited a trend opposite that of transport. The partition coefficient ratio of bovine choroid-Bruch's layer to sclera was approximately 1, 1.5, 1.7, 2, and 3.5, respectively, for the solutes, as listed earlier.
CONCLUSIONS: The choroid-Bruch's layer is a more significant barrier to drug transport than is sclera. It hinders the transport of lipophilic solutes, especially a cationic solute, more than hydrophilic solutes and in a more dramatic way than does sclera. The reduction in transport across this layer directly correlates with solute binding to the tissue. Understanding the permeability properties of sclera and underlying layers would be beneficial in designing better drugs for transscleral delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003447      PMCID: PMC3324974          DOI: 10.1167/iovs.06-0404

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  41 in total

Review 1.  Collagen gel systems for sustained delivery and tissue engineering.

Authors:  Donald G Wallace; Joel Rosenblatt
Journal:  Adv Drug Deliv Rev       Date:  2003-11-28       Impact factor: 15.470

Review 2.  A dynamic view of cellular processes by in vivo fluorescence auto- and cross-correlation spectroscopy.

Authors:  Kirsten Bacia; Petra Schwille
Journal:  Methods       Date:  2003-01       Impact factor: 3.608

3.  Transscleral diffusion of carboplatin: an in vitro and in vivo study.

Authors:  Amanda E Simpson; Jake A Gilbert; David E Rudnick; Dayle H Geroski; Thomas M Aaberg; Henry F Edelhauser
Journal:  Arch Ophthalmol       Date:  2002-08

4.  Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

Authors:  Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.

Authors:  Uday B Kompella; Nagesh Bandi; Surya P Ayalasomayajula
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

6.  Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix.

Authors:  Jake A Gilbert; Amanda E Simpson; David E Rudnick; Dayle H Geroski; Thomas M Aaberg; Henry F Edelhauser
Journal:  J Control Release       Date:  2003-05-20       Impact factor: 9.776

7.  In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system.

Authors:  Lars P J Cruysberg; Rudy M M A Nuijts; Dayle H Geroski; Leo H Koole; Fred Hendrikse; Henry F Edelhauser
Journal:  J Ocul Pharmacol Ther       Date:  2002-12       Impact factor: 2.671

8.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

Review 9.  Pharmacologic therapy for diabetic retinopathy.

Authors:  Matthew A Speicher; Ronald P Danis; Mark Criswell; Linda Pratt
Journal:  Expert Opin Emerg Drugs       Date:  2003-05       Impact factor: 4.191

10.  Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.

Authors:  Karen G Carrasquillo; Joseph A Ricker; Ioannis K Rigas; Joan W Miller; Evangelos S Gragoudas; Anthony P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  34 in total

1.  In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment.

Authors:  Paul Missel; James Chastain; Ashim Mitra; Uday Kompella; Viral Kansara; Sridhar Duvvuri; Aniruddha Amrite; Narayan Cheruvu
Journal:  J Ocul Pharmacol Ther       Date:  2010-04       Impact factor: 2.671

Review 2.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

3.  Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.

Authors:  Henry F Edelhauser; Cheryl L Rowe-Rendleman; Michael R Robinson; Daniel G Dawson; Gerald J Chader; Hans E Grossniklaus; Kay D Rittenhouse; Clive G Wilson; David A Weber; Baruch D Kuppermann; Karl G Csaky; Timothy W Olsen; Uday B Kompella; V Michael Holers; Gregory S Hageman; Brian C Gilger; Peter A Campochiaro; Scott M Whitcup; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-11       Impact factor: 4.799

4.  Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

Authors:  Rajendra S Kadam; Narayan P S Cheruvu; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

5.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

6.  Interaction between topically and systemically coadministered P-glycoprotein substrates/inhibitors: effect on vitreal kinetics.

Authors:  Ketan Hippalgaonkar; Ramesh Srirangam; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  Drug Metab Dispos       Date:  2010-07-01       Impact factor: 3.922

7.  Prediction of passive drug permeability across the blood-retinal barrier.

Authors:  Aapo Tervonen; Iina Vainio; Soile Nymark; Jari Hyttinen
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

8.  Choroidal γδ T cells in protection against retinal pigment epithelium and retinal injury.

Authors:  Zhenyang Zhao; Yuejin Liang; Yin Liu; Pei Xu; Miles J Flamme-Wiese; Deming Sun; Jiaren Sun; Robert F Mullins; Yan Chen; Jiyang Cai
Journal:  FASEB J       Date:  2017-07-20       Impact factor: 5.191

9.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

10.  Transscleral diffusion of ethacrynic acid and sodium fluorescein.

Authors:  Cheng-Wen Lin; Yong Wang; Pratap Challa; David L Epstein; Fan Yuan
Journal:  Mol Vis       Date:  2007-02-22       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.